FDA targets unapproved nausea drugs

The FDA announced last week that it was asking manufacturers of a certain type of nausea-treating drug to stop making and marketing the products. Specifically, the FDA targeted manufacturers of suppository drug products containing trimethobenzamide hydrochloride because they are not FDA-approved. This action is part of an ongoing FDA effort to root out prescription drugs that do not have FDA approval.

For the full article.

Lawyer Monthly - Legal Awards Winner
The National Trial Lawyers
Elder Care Matters Alliance
American Association for Justice
Fellow Litigation Counsel of America
Super Lawyers